— Know what they know.
Not Investment Advice

HCANF OTC

Halo Collective Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -97.1% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 51 · $15081 mcap · 149M float · 0.0001% daily turnover

Cash Flow Trends

Operating Cash Flow
-$12M +65.3% ▲
Capital Expenditures
$2M +47.8% ▲
5Y CAGR: -7.3%
Free Cash Flow
-$14M +63.9% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$894K +51.4% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
— Operating Activities —
Net Income-$14M-$28M-$41M-$97M-$85M
Depreciation & Amort.$653K$2M$2M$4M$3M
Stock-Based Comp.$0$9M$10M$11M$12M
Change in Working Capital-$4M-$741K$2M-$8M$6M
Other Non-Cash Items$4M$4M$17M-$6M$51M
Operating Cash Flow-$12M-$15M-$10M-$35M-$12M
— Investing Activities —
Capital Expenditures-$3M-$2M-$4M-$3M-$2M
Acquisitions (Net)$20K$0$846K$3M-$430K
Investment Purchases-$50K$0$0$0$0
Investment Sales$30K$186K$0$0$0
Other Investing$221K$0$0$0$2M
Investing Cash Flow-$3M-$2M-$3M$209K$254K
— Financing Activities —
Net Debt Issuance$7M-$718K$3M$2M$3M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$12M-$1M-$153K$271K$0
Financing Cash Flow$16M$22M$10M$33M$11M
Net Change in Cash$578K$5M-$2M-$2M-$894K
Cash End of Period$723K$6M$4M$2M$944K
Free Cash Flow-$16M-$17M-$14M-$38M-$14M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms